Scoping Review on Personalized Antiplatelet Therapy for Acute Coronary Syndrome

A scoping review of 346 studies published between 2010 and 2025, examining the role of platelet function testing and genotyping in managing acute coronary syndrome. The dataset was created by Jeenal Venissa Rebello and includes studies with sample sizes ranging from 13 to 10,048 patients. It was last updated on April 20, 2026.

Use Cases

• Systematic literature review based on the aggregated findings from 346 studies.
• Meta-analysis of study heterogeneity based on reported variations in design, sample size, and outcomes.
• Evaluating the clinical utility of platelet function tests like VerifyNow and LTA based on the described facilitating factors and challenges.
• Investigating the association between genetic polymorphisms and treatment response based on the reported evidence.

Strengths

• Includes 346 studies, providing a broad evidence base.
• Covers a 15-year time range (2010-2025) of relevant literature.
• Explicitly lists specific platelet function test techniques mentioned in the description, such as VerifyNow and LTA.

Limitations

• Row count for the underlying data is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small (193.2 KB), indicating limited raw data scope.

Provenance

Source

figshare

Collection Method

Scoping review conducted using Arksey and O’Malley’s five-step framework, sourcing from PubMed, Embase, and Scopus.

Time Range

2010 to 2025

Freshness

Last updated 2026-04-20 10:18:55; freshness should be verified.